UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 27

Sortiert nach

Alterations of gut microbiome in autoimmune hepatitis

Gut, 2020-03, Vol.69 (3), p.569

2020

Volltextzugriff (PDF)

Intestinal homeostasis in autoimmune liver diseases

Chinese medical journal, 2022-07, Vol.135 (14), p.1642-1652

2022

Volltextzugriff (PDF)

Alterations in microbiota and their metabolites are associated with beneficial effects of bile acid sequestrant on icteric primary biliary Cholangitis

Gut microbes, 2021-01, Vol.13 (1), p.1946366-1946366

2021

Volltextzugriff (PDF)

Epigenetics of autoimmune liver diseases: current progress and future directions

Journal of bio-X research, 2019-03, Vol.2 (1), p.46-55

2019

Volltextzugriff (PDF)

TOP-561 Butyrate induces epigenetic and metabolic reprogramming in myeloid-derived suppressor cells to alleviate primary biliary cholangitis

Journal of hepatology, 2024-06, Vol.80, p.S271-S271

2024

Volltextzugriff (PDF)

Reply to: “ARID3A variant and the risk of primary biliary cholangitis in a Central European cohort”

Journal of hepatology, 2024-06, Vol.80 (6), p.e258-e259

2024

Volltextzugriff (PDF)

MutT Homolog 1 Inhibitor Karonudib Attenuates Autoimmune Hepatitis by Inhibiting DNA Repair in Activated T Cells

Hepatology communications, 2022-05, Vol.6 (5), p.1016-1031

2022

Volltextzugriff (PDF)

Altered faecal microbiome and metabolome in IgG4-related sclerosing cholangitis and primary sclerosing cholangitis

Gut, 2022-05, Vol.71 (5), p.899

2022

Volltextzugriff (PDF)

A+T rich interaction domain protein 3a (Arid3a) impairs Mertk-mediated efferocytosis in cholestasis

Journal of hepatology, 2023-12, Vol.79 (6), p.1478-1490

2023

Volltextzugriff (PDF)

Itaconate inhibits CD103+ TRM cells and alleviates hepatobiliary injury in mouse models of primary sclerosing cholangitis

Hepatology (Baltimore, Md.), 2024-01, Vol.79 (1), p.25-38

2024

Volltextzugriff (PDF)

The Clinical Significance of Hepatic CD69+CD103+CD8+ Resident‐Memory T Cells in Autoimmune Hepatitis

Hepatology (Baltimore, Md.), 2021-08, Vol.74 (2), p.847-863

2021

Volltextzugriff (PDF)

P4HA2 induces hepatic ductular reaction and biliary fibrosis in chronic cholestatic liver diseases

Hepatology (Baltimore, Md.), 2023-07, Vol.78 (1), p.10-25

2023

Volltextzugriff (PDF)

A functional characteristic of cysteine‐rich protein 61: Modulation of myeloid‐derived suppressor cells in liver inflammation

Hepatology (Baltimore, Md.), 2018-01, Vol.67 (1), p.232-246

2018

Volltextzugriff (PDF)

No association found between the promoter variations of QKI and schizophrenia in the Chinese population

Progress in neuro-psychopharmacology & biological psychiatry, 2009-02, Vol.33 (1), p.33-36

2009

Volltextzugriff (PDF)

No genetic association between NCAM1 gene polymorphisms and schizophrenia in the Chinese population

Progress in neuro-psychopharmacology & biological psychiatry, 2008-10, Vol.32 (7), p.1633-1636

2008

Volltextzugriff (PDF)

Long noncoding RNA profiles identify five distinct molecular subtypes of colorectal cancer with clinical relevance

Molecular oncology, 2014-12, Vol.8 (8), p.1393-1403

2014

Volltextzugriff (PDF)

No genetic association between polymorphisms in the kainate-type glutamate receptor gene, GRIK4, and schizophrenia in the Chinese population

Progress in neuro-psychopharmacology & biological psychiatry, 2008-04, Vol.32 (3), p.876-880

2008

Volltextzugriff (PDF)

Genome‐wide meta‐analysis identifies susceptibility loci for autoimmune hepatitis type 1

Hepatology (Baltimore, Md.), 2022-09, Vol.76 (3), p.564-575

2022

Volltextzugriff (PDF)

NUDT1 promotes the accumulation and longevity of CD103+ TRM cells in primary biliary cholangitis

Journal of hepatology, 2022-11, Vol.77 (5), p.1311-1324

2022

Volltextzugriff (PDF)

Genome‐wide Association Studies of Specific Antinuclear Autoantibody Subphenotypes in Primary Biliary Cholangitis

Hepatology (Baltimore, Md.), 2019-07, Vol.70 (1), p.294-307

2019

Volltextzugriff (PDF)

The Immunobiology of Receptor Activator for Nuclear Factor Kappa B Ligand and Myeloid‐Derived Suppressor Cell Activation in Immunoglobulin G4–Related Sclerosing Cholangitis

Hepatology (Baltimore, Md.), 2018-11, Vol.68 (5), p.1922-1936

2018

Volltextzugriff (PDF)

Corrigendum to: “An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs” [J Hepatol 75 (2021) 572-581]

Journal of hepatology, 2023-04, Vol.78 (4), p.883-883

2023

Volltextzugriff (PDF)

Itaconate inhibits CD103 + T RM cells and alleviates hepatobiliary injury in mouse models of primary sclerosing cholangitis

Hepatology (Baltimore, Md.), 2024-01, Vol.79 (1), p.25-38

2024

Volltextzugriff (PDF)

The cumulative effects of known susceptibility variants to predict primary biliary cirrhosis risk

Genes and immunity, 2015-04, Vol.16 (3), p.193-198

2015

Volltextzugriff (PDF)

Association and expression studies of glutamate-cysteine ligase modifier (GCLM) and schizophrenia in the Chinese Han population

Psychiatric genetics, 2009-10, Vol.19 (5), p.279-280

2009

Volltextzugriff (PDF)

1 – 25 von 27

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieClinical Reviews In Allergy & Immunology

Zeitschrift / SeriePlos One

KollektionJournals@Ovid

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(27)
Mit Volltextzugriff
(22)

Publikationsform

Artikel
(27)

Sprache

Englisch
(27)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Alterations of gut microbiome in autoimmune hepatitis

Intestinal homeostasis in autoimmune liver diseases

Alterations in microbiota and their metabolites are associated with beneficial effects of bile acid sequestrant on icteric primary biliary Cholangitis

Epigenetics of autoimmune liver diseases: current progress and future directions

TOP-561 Butyrate induces epigenetic and metabolic reprogramming in myeloid-derived suppressor cells to alleviate primary biliary cholangitis

Reply to: “ARID3A variant and the risk of primary biliary cholangitis in a Central European cohort”

MutT Homolog 1 Inhibitor Karonudib Attenuates Autoimmune Hepatitis by Inhibiting DNA Repair in Activated T Cells

Altered faecal microbiome and metabolome in IgG4-related sclerosing cholangitis and primary sclerosing cholangitis

A+T rich interaction domain protein 3a (Arid3a) impairs Mertk-mediated efferocytosis in cholestasis

Itaconate inhibits CD103+ TRM cells and alleviates hepatobiliary injury in mouse models of primary sclerosing cholangitis

The Clinical Significance of Hepatic CD69+CD103+CD8+ Resident‐Memory T Cells in Autoimmune Hepatitis

P4HA2 induces hepatic ductular reaction and biliary fibrosis in chronic cholestatic liver diseases

A functional characteristic of cysteine‐rich protein 61: Modulation of myeloid‐derived suppressor cells in liver inflammation

No association found between the promoter variations of QKI and schizophrenia in the Chinese population

No genetic association between NCAM1 gene polymorphisms and schizophrenia in the Chinese population

Long noncoding RNA profiles identify five distinct molecular subtypes of colorectal cancer with clinical relevance

No genetic association between polymorphisms in the kainate-type glutamate receptor gene, GRIK4, and schizophrenia in the Chinese population

Genome‐wide meta‐analysis identifies susceptibility loci for autoimmune hepatitis type 1

NUDT1 promotes the accumulation and longevity of CD103+ TRM cells in primary biliary cholangitis

Genome‐wide Association Studies of Specific Antinuclear Autoantibody Subphenotypes in Primary Biliary Cholangitis

The Immunobiology of Receptor Activator for Nuclear Factor Kappa B Ligand and Myeloid‐Derived Suppressor Cell Activation in Immunoglobulin G4–Related Sclerosing Cholangitis

Corrigendum to: “An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs” [J Hepatol 75 (2021) 572-581]

Itaconate inhibits CD103 + T RM cells and alleviates hepatobiliary injury in mouse models of primary sclerosing cholangitis

The cumulative effects of known susceptibility variants to predict primary biliary cirrhosis risk

Association and expression studies of glutamate-cysteine ligase modifier (GCLM) and schizophrenia in the Chinese Han population

Aktive Filter

Suchergebnisse filtern